Showing results (201-210 of 369) with videos related to

Sort By:
Pageof 37
European Urology|April 23, 2020
Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical CharacteristicsBastien Nguyen, Jose Mauricio Mota, Subhiksha Nandakumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
BJU International|August 16, 2014
Enzalutamide in European and North American men participating in the AFFIRM trialAxel S Merseburger, Howard I Scher, Joaquim Bellmunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancerMichael J Morris, William P Tong, Carlos Cordon-Cardo, et al.
Nuclear Medicine Communications|February 28, 2012
Computer-aided quantitative bone scan assessment of prostate cancer treatment responseMatthew S Brown, Gregory H Chu, Hyun J Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate CancerHimisha Beltran, Adam Jendrisak, Mark Landers, et al.
Molecular & Cellular Proteomics : MCP|July 25, 2014
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancerArpi Nazarian, Kevin Lawlor, San San Yi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancerJorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
The Journal of Clinical Investigation|March 4, 2010
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesisAndrea Alimonti, Caterina Nardella, Zhenbang Chen, et al.
Cancer Research|February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomyAnuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Pageof 37